High-dose intravenous immunoglobulin versus albumin 4% in paediatric toxic shock syndrome: a randomised controlled feasibility study.
Aurélie PortefaixCarole DhelensMorgan RecherFleur Cour-AndlauerJérôme NaudinGuillaume MortametNicolas JoramPierre TissièresTiphanie GinhouxBehrouz KassaiFlorent BoutitieDelphine Maucort-BoulchEtienne JavouheyPublished in: Archives of disease in childhood (2024)
NCT02219165.